In murine models, the bystander memory CD8+ T-cells induced by these therapies proliferate and exhibit effector functions without the need for TCR engagement and produce significant anti-tumor effects which are dependent on IFN-g, IL-12, and Fas ligand expression but independent of CD4+ T-cells, NK cells, and perforin (69, 70). Here, CD8A is linked to neoplasm.